Introduction

Continuous glucose mon itor i ng (CGM)
1 has become a useful diagnostic tool in the treatment of the individual patient, 2 and substantial efforts have gone into developing derived variables that can be related to meaningful clinical outcomes. Because of the importance of hypoglycemia prediction, particular attention has been given to measures of variability where CGM provides dramatically more information than has been available previously. Researchers have applied previously developed measures of variability-standard deviation, 3 M value, 4 mean amplitude of glycemic excursions, 5, 6 J value, low glucose risk index, 7 and blood glucose (BG) rate of change 8 -and come up with new ones, including continuous overall net glycemic action. 9 When derived directly from raw data, each of these variables contains both signal and noise from the measurement technology, and inherent in this data reduction to a single number is an incorporation of measurement-related variability not attributable to the patient's condition.
We proposed applying the standard data reduction methodology of the discrete Fourier transform to CGM data that, among other benefits, addresses those issues. The Fourier approximation method provides the following.
• An overall statistical model for assessing the patient's whole blood glucose profile providing the dimension reduction necessary for insightful analyses of the whole function.
• The ability to smooth out extraneous variability in CGM plots by filtering out the high-frequency noise inherent in the CGM measurement process. A useful attribute is that the degree of noise reduction is adaptable to any particular analysis.
• Partitioning the blood glucose profile into a 24-hour mean and component harmonic oscillations about the mean.
• Definitions of new parameters based on 24-hour Fourier profiles, which may have clinical utility.
While individual parameters from discrete Fourier transformation may prove useful as predictors of morbidity, such transformation initially may enhance the utility of the variables mentioned earlier due to the noise elimination it can provide. Furthermore, because the function after discrete Fourier transformation still retains most of the meaningful information about the individual CGM curve, it can be utilized in relation to any clinical outcome whether related to average glycemic exposure, precipitous glucose decreases, low glucose values, or perhaps for oxidative stress, particularly high glucose values. 10, 11 No a priori assumptions about pathogenesis have to be made.
In this article, we applied the discrete Fourier transform to CGM data and explored some of the possible utilities with data primarily from adolescent type 1 diabetes patients.
Methods
Model Considerations
Discrete Fourier transformation requires selection of the longest possible cycle for which there are data. In this article, 24-hour periods were selected as the longest cycle because whole function summaries were made based on cohorts of patients, many of whom had only one continuous 24-hour period of usable data. Also, because of the circadian cycle of 24 hours, this cycle time made physiologic sense. When CGM devices with longer sample times become available, a 7-day cycle due to changed food and exercise behavior during the weekend or even a monthly cycle to account for menstrual cycle impact on glycemic control may yield additional information.
The start/end time of a 24-hour cycle can be designated at any time since the CGM monitor continues. It is convenient to select the start/end time of the 24-hour cycle to be midnight so that the horizontal scale begins at midnight (hour 0) and ends at midnight (hour 24 = hour 0). Hence, the date of the 24-hour session becomes the key identification in data analysis. Patients with more than one contiguous 24-hour session would then have, in effect, more than one data "point" (i.e., whole 24-hour function) for the analysis. These can be averaged so that each patient contributes one "point" per specified visit, or the sampling unit can be identified as each individual 24-hour session and patient effects can be accounted for in mixed models.
Fourier Model
Suppose the function obtained from the CGM monitor has the form
where t is in hours from 0 (midnight) to 24 (midnight) and G is the observed CGM BG sensor reading at time t. Here it is convenient to assume that G is observed for every time t even though in reality it is generally observed every 5 minutes. The Fourier approximation to this function has the form
where cycle i (t) is a periodic function that runs through exactly i complete cycles in 24 hours. 12 In other words, its frequency of oscillation is i and the time required to complete one cycle is 24/i hours, which is called the period. The function cycle i (t) is called the ith harmonic component of the overall function, and two parameters are needed to completely define the ith harmonic, the amplitude and phase shift. The constant m is also the mean of the Fourier approximating function fh because the 24-hour mean of each of the harmonic functions is zero. This is an important characteristic of the Fourier approximation, namely apart from the overall mean m the rest of the approximating function is modeling only the BG variability and is decomposing this variability into harmonic components.
There is another important characteristic of the cycles cycle i (t). These cycles are mutually orthogonal in the sense that they are uncorrelated, that is, the integral or sum of the product of any two of them over 24 hours is zero (provided all CGM readings are present over 24 hours and spaced equally). The very important consequence of this is that the fitted coefficients for an individual cycle do not depend on other cycles within the multiple regressions. Each individual estimated cycle remains unchanged regardless of the number of cycles chosen for the model.
The full definition of the harmonic function cycle i (t) is
where A i is the amplitude and PHS i is the phase shift; both are determined based on obtaining the best approximation to the observed CGM BG function f. The phase shift PHS i moves the cosine curve to the right or left in order to locate the maximum and minimum values of the harmonic to best represent the overall BG curve.
The harmonic determined by cycle i (t) is linear in amplitude A i but not linear in the phase shift-PHS i . This would appear to eliminate the standard multiple regression statistical software for estimating the parameters of the harmonic functions. However, the cosine function is converted readily to another form that is linear in the unknown parameters that must be estimated. Hence, the ith harmonic can be written as
which is an equivalent expression for the ith harmonic function, with
Hence, the Fourier approximation to G = f(t) starts with
which is a multiple linear regression in the terms cos(2π i t/24) and sin(2π i t/24).
Statistical Test for Zero Amplitude
After a Fourier transformation of individual CGM data sets, it is useful to aggregate data across patients to a group function when assessing the impact, for example, of a treatment intervention within a clinical trial. This is done simply by calculating the means of the individual patient C and S values for each cycle. A critical consideration is whether this sample size is adequate to detect the given cycles. Let Cbar and Sbar be sample means of cosine and sine regression coefficients for cycle i from a sample of n patients' 24-hour CGM system profiles, as in Equation (6 has an F distribution with 2 df, n -2 df assuming that the population amplitude = 0 for this cycle (the null hypothesis that both C and S are zero in the population for this cycle). In other words, Fstat is a test statistic that can be applied to each cycle for determining whether there is sufficient precision or sufficient sample size for detecting the presence of a particular harmonic cycle. This statistic is Hotelling's T 2 test.
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The resulting p value should be adjusted to take into account the multiple tests, one for each cycle. There are many ways this can be done, and one procedure utilizes a standard multiple comparison method at each cycle, the idea being that if cycle k is being tested, then this must be the kth test so that significance at the p = 0.05 level should take this into account. This yields a procedure where higher cycles are subjected to a successively more stringent criterion. This adjustment is given by
where p is obtained from the Hotelling T 2 test. This adjustment uses the Bonferonni method.
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Use of Derivatives to Identify Maxima for Rate of Change
One advantage of representing the 24-hour CGM with defined mathematical functions is the ability to obtain stable estimates of rates of change at specific times. One such parameter, termed average steepest descent, can be defined only after the raw CGM curve has been approximated by a smooth function. The average steepest descent is defined in the following two-step process using a smooth (Fourier) approximation to a patient's 24-hour CGM function.
Solve for the relative minima of the first derivative of the CGM approximation (find the times at which the curve has its greatest local descent).
Average the resulting steepest descents (the first derivative values at these times).
1.
2.
Because the Fourier approximation involves only sines and cosines, it is relatively easy to perform step 1 and hence step 2 using the Newton-Raphson method.
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Applications where descents of relatively long duration are desired require a Fourier approximation of no more than five cycles.
Results
Illustrative Example of Individual CGM Trace Transformation
Figures 1A and 1B illustrate a 24-hour CGM curve from a patient with type 2 diabetes treated with a combination of metformin, glipizide, and insulin glargine at bedtime. Superimposed on the curve is graphic representation of the functions derived by Fourier transformation with 5 and 20 cycles, respectively. The higher frequency residuals, or differences from the approximation and the actual BG readings, are also depicted. The use of just 5 cycles (11 degrees of freedom) in Figure 1A captures the essence of this particular patient's glucose curve with apparent nighttime hypoglycemia and relatively early breakfast and lunch with relatively steep decreases after those two meals. However, the 5 cycles are not sufficient to catch the extremes of the peaks and valleys with deviations from the original curve of up to 40 mg/dl, and the error plot reveals some regular oscillations remaining, suggesting that higher frequency harmonics may be required.
When using 20 harmonic functions (41 degrees of freedom) the model curve, except for some minor spikes, essentially retraces the original curve and the error plot no longer reveals a periodic pattern, possibly indicating it is now reduced to random noise. Furthermore, note that the approximating Fourier model converges uniformly to the observed CGM curve over all times within the 24-hour period (except at times 0 and 24). This uniform convergence is a well-known and useful property of Fourier approximations.
Example of Test for Zero Amplitude
The following examples are drawn from a prospective clinical trial of girls and boys between 9 and 17 years of age with a Tanner stage of ≥2 who had a diagnosis of type 1 diabetes mellitus for at least 1 year for which they were treated with neutral protamine Hagedorn (NPH) as the basal insulin. They had a C-peptide concentration ≤0.5 nmol/liter and 7.0% ≤ hemoglobin A1c (HbA1c) ≤ 9.5% at screening and were randomized to either continue on their previous insulin regimen or be treated with insulin glargine in combination with insulin lispro in a typical multiple daily injection regimen.
The test for zero amplitude on the baseline sample of 90 patients with CGM recordings is shown in Table 1 . According to the adjusted p values, there is strong evidence for detecting nonzero amplitudes for cycles 1 through 5. However, because the unadjusted p value for cycle 9 was under 0.05, there may be some evidence of higher frequencies, which perhaps would be detected readily with larger sample sizes. Table 2 shows baseline estimates and estimates of changes from baseline for the treatment group randomized to glargine in combination with lispro multiple daily injection therapy of the five cycles demonstrated earlier to be adequately supported by the amount of data available. The estimates were not sample means, but were generated from a mixed repeated measures model of the 11 Fourier parameters.
Group Comparison Example: Individual Harmonic Components and Graphical Representation
There was a nonsignificant reduction of 18 mg/dl in the 24-hour mean BG level. While it may be surprising that this apparently substantial change is not statistically significant, it should be kept in mind that the standard measure of average glycemic control HbA1c is inherently an average over time and therefore can be suspected to be much more stable than a single or a couple of days worth of CGM. Regarding the harmonic amplitudes, the amplitudes decline with increasing frequency. A numerical decrease in the largest amplitude and significant reductions in the amplitudes for harmonics 2, 3, and 4 were observed, and surprisingly the estimated reductions for harmonics 2 and 3 were larger than for harmonic 1. The phase shifts for each harmonic are approximately half of the harmonic period and are not changed much.
Results are easily plotted in Figure 2 to facilitate comprehension for nonmathematicians. Dotted line curves represent one standard error of the week 12 baseline difference at each time t, and it is evident that the curve separation is small when judged by the precision at each individual time point. Summaries of the curves, such as the 24-hour means or individual harmonic amplitudes, utilize the whole curve and hence carry more precision so that some differences between 12 weeks and baseline do achieve statistical significance. However, it is clear that more than 45 patients are required to separate the curves. Even with this sample size limitation, it is clear that the observed reductions in harmonics 2 through 4 reflect a diminished postbreakfast glycemic surge. Despite similar average trough glucose during the night of about 170 mg/ dl, the peak postbreakfast glucose is diminished from about 235 to 205 mg/dl.
Clinical Results: Effect of Harmonics 2 and 3 on HbA1c
Each of the patients in the aforementioned study had HbA1c values determined at baseline and at week 24. It was therefore possible to determine whether any of the Fourier parameters had additional prognostic value for predicting the mean week 24 HbA1c after taking into account the effects of the usual baseline predictors, particularly baseline HbA1c. The patient's postbaseline randomized study arm was also taken into account in the model, with 45 patients in the glargine arm and 45 patients in the intermediate-acting insulin arm.
Cycle 2 and cycle 3 amplitudes at baseline each had a statistically significant association with the week 24 HbA1c, after accounting for baseline HbA1c. Further i nvest igat ion revealed that th is associat ion was particularly strong when cycle 2 and cycle 3 harmonic functions were combined, and the amplitude of the resulting sum was used as one prognostic factor. This amplitude was
The multiple linear regression of the 90 patients had week 24 HbA1c as the dependent variable and the following terms as independent variables: baseline HbA1c, baseline mean 24-hour BG (from the CGM records), the amplitude of the first cycle (A 1 ), the combined amplitudes of cycles 4 and 5, patient age, and study arm (which had little effect for these patients). Results of this model indicated that larger values of Amp23 at baseline yielded larger mean week 24 HbA1c levels for the same baseline HbA1c Plus or minus one SE of the difference in means is depicted from the average of the curves at each time. The insulin glargine reduction from baseline in the 24-hour mean did not quite achieve statistical significance (NS: 0.05 < p < 0.1). However, the reduction from baseline in the CGM 24-hour standard deviation was statistically significant (p = 0.002). (p < 0.001). Baseline HbA1c was a significant predictor of week 24 HbA1c (p < 0.05), but the other terms did not achieve statistical significance.
To illustrate the effect graphically, patients were categorized as having low, medium, or high values of Amp23 at baseline, and these categories were entered into the model rather than the single linear term. Values defining low, medium, and high were chosen to divide the cohort of 90 patients into approximately equal groups, and patients classified as having a high amplitude for their 2nd + 3rd harmonic functions had a significantly higher mean HbA1c at week 24 (p = 0.003). Results are depicted in Figure 3A . Because the 24-hour mean BG is known to be correlated with HbA1c, perhaps either the mean BG or HbA1c should have been in the model, but not both. However, the result was the same regardless of which combination of baseline HbA1c, mean BG was used. The scatter plots of week 24 HbA1c versus baseline Amp23 (adjusted for the other baseline factors) in Figure 3B show that this relationship was generally linear across all points, so the original linear model provided a reasonable fit. The low, medium, and high values from Figure 3A do not apply directly to the x axis of Figure 3B , as both the x and the y axes from Figure 3B were obtained by adjusting for the other factors in the model.
Clinical Results: Effect Average Steepest Descent on Hypoglycemia
A measure of average steepest descent for each 24-hour profile obtained at baseline from a cohort of 90 type 1 pediatric patients was used in conjunction with the study arm and other baseline parameters to predict the rate of subsequently reported symptomatic hypoglycemia confirmed with BG <50 mg/dl occurring between the hours of 6 AM and noon during the 24 study weeks. The log-linear relationship between the average steepest descent and the reported hypoglycemia rate by treatment group is depicted in Figure 4 . Patients with steeper average descents had higher rates of hypoglycemic events occurring. This relationship was statistically significant for patients in the NPH insulin group with the hypoglycemia rate estimate doubled for every decline of -9 mg/dl in average steepest descent (p < 0.005), while it was in the same direction but not statistically significant (p > 0.1) in the insulin glargine group.
Discussion
Studying CGM 24-hour plots for different patients suggests characteristics that need to be present for a useful functional approximation. First, the glucose rises and falls cyclically in relation to a baseline as expected with diet and physical activity as well as drug action.
Second, there appears to be a relatively high-frequency, low-amplitude oscillation (up and down) motion in the plots. This article considers the latter white noise originating from the CGM meter measurement of the signal and not from fluctuations in the actual BG. Useful functional approximations of BG concentration must be able to filter out this high-frequency noise. What remains is a curve that still rises, falls, and returns to approximately the original starting point as expected. In other words, a typical CGM curve is not some linear or monotonic function amenable to a low-degree polynomial approximation, but something suggesting a combination of sine and cosine functions. These considerations make the Fourier model a method of choice in developing approximating functions for CGM assessments. 
A B
For analysis of groups of patients, this methodology has the advantage of making the determination of the required number of cycles depend on a standard objective statistical criterion. When approximating an individual patient trace the number of cycles chosen would depend on the error the user is willing to accept and therefore is a matter of choice evaluating not only the size, but also any possible structure in the residual error (compare Figures 1A and 1B) .
From a theoretical point of view the discrete Fourier transform therefore appears to be a very attractive functional description of CGM data, if for nothing else as a noise reduction procedure before calculating already established measures of variability.
While advocates of transformed data for glucose values such as M value and "low blood glucose index" 7 may be "right" given the skewed distribution of glucose concentrations in diabetes patients, transforming raw data also transforms the noise. While it may be necessary at times to transform the blood glucose signal that can vary exponentially because of among-patient variation, the white noise component from the measurement itself may not require transformation. This again suggests that the high-frequency noise be filtered out prior to transformation, but more research is required to determine whether the Fourier transform for this purpose is of benefit for improving prediction clinical outcomes.
For analysis of clinical trial data, dimension reduction across groups without loss of essential information is of critical importance. In this context, the three chosen examples demonstrate a few of the possible applications of the discrete Fourier transform. Dimension reduction enables a unified comparison of the full group functional forms rather than a comparison of isolated derived variables that by nature fragment and eliminate critical information. The third example shows a particularly useful application of the smooth functional expression of CGM data because the symptoms of hypoglycemia physiologically involve a counterregulatory response that may be precipitated as much by the change in glucose as by the absolute glucose value itself. While rate of change has been used previously to describe glucose curves, 8 it is relevant that reference to the smooth functional approximation of the CGM profile was made only after failure to demonstrate any hypoglycemia predictive value from measures of low glucose at baseline. Smooth functional approximation of data permitted identification of the time points with the highest velocity downward simply by finding the point where the second derivative of the function was zero using undergraduate level mathematics. Further research will relate the exact time point of symptomatic hypoglycemia reported by the patient to CGM data. From this and empirical data we should be able to determine to what degree reported hypoglycemia by patients is related to the absolute blood glucose level, to the rate of changing glucose, or even to the rapidity with which the rate of change changes or, in other words, the acceleration.
This article focused on one data set from a prospective randomized comparative trial of adolescent type 1 diabetes patients. While space prohibits demonstration of further data, the discrete Fourier transform as a method of analysis has additionally been tested in a database of healthy volunteers, two type 2 diabetes prospective randomized treatment intervention trials, and finally an adult type 1 diabetes study and has shown equal promise there reproducing some of the findings from this article. Further work is needed to further validate this approach, and ultimately only application in morbidity and mortality trials will truly define the value of such methodology.
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